Drug use in prisons: strategies for harm reduction (ANRS-PRIDE Program)

被引:1
|
作者
Michel, Laurent [1 ]
机构
[1] Ctr Pierre Nicole, Ctr Rech Epidemiol & Sante Populat, 27 Rue Pierre Nicole, F-75005 Paris, France
来源
CIENCIA & SAUDE COLETIVA | 2016年 / 21卷 / 07期
关键词
Prison; Drug use; Harm reduction; Recommendations; France; FRENCH PRISONS; PUBLIC-HEALTH; ACCESS; HIV; PREVALENCE; DISORDERS;
D O I
10.1590/1413-81232015217.28442015
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The existence of risky practices related to drug use inside prisons is a reality everywhere and is a major issue for the community as a whole. The level of implementation of harm reduction (HR) measures recommended by the World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC) is very often poor and reveals inadequate concern about public health issues in the prison environment, without any respect for the principle of equivalence for prevention and health assistance with the general community. In 2009, the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) developed a comprehensive research program focusing on the prevention of infectious risks in prison settings. Different steps were defined and scheduled, and included i) an inventory of harm reduction (HR) measures, ii) a qualitative survey on the reality of risky practices, iii) an assessment of the social acceptability of HR measures, and iv) an intervention trial exploring the feasibility of upgrading existing HR strategies. A progressive implementation of this program has shown it is feasible, but in France, it requires tenacity, simple long-term objectives, support from a scientific authority, pedagogical interventions for all involved, as well as constant discussion with the authorities. The implementation of this program in other countries is equally simple to manage.
引用
收藏
页码:2081 / 2088
页数:8
相关论文
共 50 条
  • [41] Strategies and outcomes in translating alcohol harm reduction research into practice: the Alcohol Linking Program
    Wiggers, J
    Jauncey, M
    Considine, R
    Daly, J
    Kingsland, M
    Purss, K
    Burrows, S
    Nicholas, C
    Waites, RJ
    DRUG AND ALCOHOL REVIEW, 2004, 23 (03) : 355 - 364
  • [42] Limited impact of the harm-reduction policy on HCV among drug-users. The ANRS-Coquelicot survey example
    Jauffret-Roustide, M.
    Emmanuelli, J.
    Desenclos, J. C.
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2006, 54 : 1S53 - 1S59
  • [44] Informative group: harm reduction strategies for people apprehended for illicit drug consumption and/or possession
    Pinto, Leila de Oliveira
    de Oliveira, Daniele Jesus
    Ribeiro Duarte, Fabia Maria
    INTERFACE-COMUNICACAO SAUDE EDUCACAO, 2015, 19 : 965 - 973
  • [45] What do law enforcement strategies contribute to UK drug harm-reduction?
    Grieve, John
    SAFER COMMUNITIES, 2009, 8 (01) : 32 - 37
  • [46] When in a drug epidemic should the policy objective switch from use reduction to harm reduction?
    Caulkins, Jonathan P.
    Feichtinger, Gustav
    Tragler, Gernot
    Wallner, Dagmar
    EUROPEAN JOURNAL OF OPERATIONAL RESEARCH, 2010, 201 (01) : 308 - 318
  • [47] Identifying harm reduction strategies for alcohol and drug-use in inpatient care settings and emergency departments: a scoping review protocol
    Curran, Janet A.
    Somerville, Mari
    Boulos, Leah
    Caudarella, Alexander
    Crowther, Daniel
    Johnson, Catie
    Wozney, Lori
    MacPhee, Shannon
    Sinclair, Douglas
    Elliott Rose, Annette
    Jose, Caroline
    Joudrey, Morgan
    BMJ OPEN, 2021, 11 (10):
  • [48] Drug use, harm reduction, and health policies in Argentina: Obstacles and new perspectives
    Inchaurraga, S
    CLINICAL INFECTIOUS DISEASES, 2003, 37 : S366 - S371
  • [49] Harm reduction and the ethics of drug use: contemporary techniques of self-governance
    Pereira, Margaret
    Scott, John
    HEALTH SOCIOLOGY REVIEW, 2017, 26 (01): : 69 - 83
  • [50] State of the art science addressing injecting drug use, HIV and harm reduction
    Beg, Monica
    Strathdee, Steffanie A.
    Kazatchkine, Michel
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 : S1 - S4